Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bronchopulmonary carcinosarcoma]

N Schmitz1, E Quoix, B Gasser

  • 1Service de pneumologie, Pavillon Laënnec, Strasbourg, France.

La Revue De Medecine Interne
|October 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.

ESMO open·2021
Same author

[Recommendations of French specialists on screening for lung cancer].

Revue des maladies respiratoires·2021
Same author

Macrophage-derived Wnt signaling increases endothelial permeability during skeletal muscle injury.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2020
Same author

Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
Same author

[Vaccines for the treatment of non-small cell lung cancer].

Revue des maladies respiratoires·2019
Same author

[Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer].

Revue de pneumologie clinique·2016
Same journal

[Atypical low back pain].

La Revue de medecine interne·2026
Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026
Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
See all related articles

Bronchopulmonary carcinosarcoma, a rare lung cancer with mixed cell types, presents similarly to epithelial tumors but has a worse prognosis. Despite high resectability, median survival is only six months.

Area of Science:

  • Oncology
  • Pulmonology
  • Pathology

Background:

  • Bronchopulmonary carcinosarcoma is a rare lung neoplasm characterized by a mixture of malignant epithelial and mesenchymal cells.
  • Its histogenesis remains largely unknown, contributing to its classification as a challenging diagnosis.

Observation:

  • A case study of a 62-year-old man with bronchopulmonary carcinosarcoma is presented.
  • The tumor exhibited clinical and radiographic features indistinguishable from common bronchopulmonary epithelial malignancies.

Findings:

  • Bronchopulmonary carcinosarcomas, despite being resectable in 90% of cases, demonstrate a significantly poorer prognosis compared to other lung cancers.
  • The median survival rate for this condition is critically low, reported at approximately six months.

Related Experiment Videos

Implications:

  • Early and accurate diagnosis is crucial for managing bronchopulmonary carcinosarcoma, despite its challenging nature.
  • Further research into the totipotential cell origin may elucidate therapeutic strategies for this aggressive lung cancer.